However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...
Piper Sandler analyst Matt O’Brien lowered the firm’s price target on DexCom (DXCM) to $75 from $100 and keeps an Overweight rating on the shares.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) securities during ...
TipRanks on MSN
DexCom price target lowered to $93 from $98 at Wells Fargo
Wells Fargo lowered the firm’s price target on DexCom (DXCM) to $93 from $98 and keeps an Overweight rating on the shares.
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective increased by research analysts at Barclays from $90.00 to $93.00 in a report issued on Monday,Benzinga reports. The brokerage presently ...
DexCom posts Q3 revenue of $1.21 billion, beating estimates and raising 2025 guidance as analysts expect strong sales and margin improvement ahead.
SINGAPORE--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback